Nagachinta, S.; Bouzo, B.L.; Vazquez-Rios, A.J.; Lopez, R.; Fuente, M.d.l.
Sphingomyelin-Based Nanosystems (SNs) for the Development of Anticancer miRNA Therapeutics. Pharmaceutics 2020, 12, 189.
https://doi.org/10.3390/pharmaceutics12020189
AMA Style
Nagachinta S, Bouzo BL, Vazquez-Rios AJ, Lopez R, Fuente Mdl.
Sphingomyelin-Based Nanosystems (SNs) for the Development of Anticancer miRNA Therapeutics. Pharmaceutics. 2020; 12(2):189.
https://doi.org/10.3390/pharmaceutics12020189
Chicago/Turabian Style
Nagachinta, Surasa, Belen Lopez Bouzo, Abi Judit Vazquez-Rios, Rafael Lopez, and Maria de la Fuente.
2020. "Sphingomyelin-Based Nanosystems (SNs) for the Development of Anticancer miRNA Therapeutics" Pharmaceutics 12, no. 2: 189.
https://doi.org/10.3390/pharmaceutics12020189
APA Style
Nagachinta, S., Bouzo, B. L., Vazquez-Rios, A. J., Lopez, R., & Fuente, M. d. l.
(2020). Sphingomyelin-Based Nanosystems (SNs) for the Development of Anticancer miRNA Therapeutics. Pharmaceutics, 12(2), 189.
https://doi.org/10.3390/pharmaceutics12020189